Side-Effect Management

Nontypical Formulation of Pazopanib Effective, and Safe With Diligent Monitoring

By

Susan Moench, PhD, PA-C

Two cases studies demonstrate whether crushed pazopanib is a feasible alternative for patients who cannot swallow the tablets whole.

Increased Risk for Mental Health Disorders Seen With Head and Neck Cancers

By

Megan Garlapow, PhD

Mental health disorders may be an adverse effect of head and neck cancer diagnosis, treatment, or treatment morbidities.

Reasons for TKI Discontinuation ID’d in Chronic Myeloid Leukemia

Treatment-free remission maintained in 14 of 21 patients who discontinued tyrosine kinase inhibitors.

Indirect Measures Demonstrated High Level of Adherence to Oral Immunomodulatory Therapy for Multiple Myeloma

By

Susan Moench, PhD, PA-C

Using separate indirect medication adherence measures, researchers determined adherence rates for patients with MM treated with oral immunomodulatory therapy.

Toolbox Enables Quick Response to Anticancer Therapy-Induced Hypersensitivity Reactions

By

Joyce Pagan

Researchers outline best practice for responding to anticancer therapy-induced hypersensitivity.

Quick Recognition of Adverse Effects Minimizes Discontinuations in Mogamulizumab Trial

By

Joyce Pagan

A review of outcomes in the MAVORIC trial for patients with CTCL who experienced treatment-related AEs.

Addition of CHG-Impregnated Dressing Dramatically Changes CLABSI Rate

By

Joyce Pagan

Including chlorhexidine gluconate-impregnated dressing in central line bundle resulted in a dramatic change in central line infections.

Patient Diaries Ensure Accurate Reports on Medication, Adverse Effects in Clinical Trial Participants

By

Joyce Pagan

Patient-completed pill and toxicity diaries were linked to medication adherence and timely management of AEs in clinical trial participants.

Preparing Nurses for Possible Adverse Events with CAR-T Therapy

By

Megan Garlapow, PhD

A multidisciplinary program developed to educate nurses on recognizing and managing the signs and symptoms of CAR-T cell therapy adverse effects.

Cancer Radiotherapy Poses Long-Term Risks for Children’s Spinal Development

By

Bryant Furlow

A report from a European working group of pediatric radiation oncologists focuses on recommendations for safer delivery of radiotherapy to children, especially in dose distributions involving spinal vertebrae.